Products under patent are available for R&D in the USA as permitted under 35 USC ยง 271(e)(1)
- Acyclovir
- Alfuzosin Hydrochloride
- Alprostadil
- Anagrelide
- Artemether
- Atracurium Besylate
- Avanafil
- Azelaic Acid
- Azithromycin Dihydrate & Monohydrate
- Bupropion Hydrochloride
- Candesartan Cilexetil
- Celecoxib
- Chlormadinone Acetate
- Clarithromycin
- Clobazam
- Clonidine Base & Hydrochloride
- Donepezil Hydrochloride
- Duloxetine Hydrochloride
- Econazole Nitrate
- Erythromycin Base
- Escitalopram Oxalate
- Famotidine
- Felodipine
- Fenofibrate
- Fluoxetine Hydrochloride
- Glimperide
- Guaifenesin
- Hydrochlorothiazide
- Irbesartan
- Isoproterenol Hydrochloride
- Losartan Potassium
- Meloxicam
- Meprobamate
- Metaxalone
- Methocarbamol
- Metoprolol Succinate & Tartrate
- Mexiletine Hydrochloride
- Miconazole Base & Nitrate
- Moxifloxacin
- Olanzapine
- Olmesartan Medoxomil
- Pramipexole
- Prasugrel
- Ropinirole Hydrochloride
- Roxithromycin
- Sodium Nitroprusside
- Valacyclovir HCI
- Vanlafaxine Hydrochloride
- Venlafaxine Hydrochloride
- Warfarin Sodium Clathrate